Podcast appearances and mentions of James D Lewis

Host: Neilanjan Nandi, MD Guest: James D. Lewis, MD, MSCE An ongoing question for clinicians and patients alike is how diet can impact IBD treatment and management. Here to discuss this topic with Dr. Neil Nandi is Dr. James Lewis of the University of Pennsylvania IBD Center. Dr. Lewis recently conducted a clinical randomized trial that compared the impact of two diets on patients with mild-to-moderate Crohn's disease symptoms, and now, Drs. Nandi and Lewis are diving into this study, the reasoning behind it, and its outcomes.

Host: Matt Birnholz, MD Guest: James D. Lewis, MD, MSCE The recipe for a healthy gut involves much more than just prescribing medications and diet restrictions. Treating the whole patient by identifying malnourishment, dermatologic conditions, and psychosocial needs can help ensure that IBD doesn’t have any negative impacts beyond the gut. Join Dr. Matt Birnholz as he digests the highlights from the 2020 Crohn's and Colitis Congress session "IBD: Beyond the Gut" with guest Dr. James Lewis.

Host: Matt Birnholz, MD Guest: James D. Lewis, MD, MSCE The recipe for a healthy gut involves much more than just prescribing medications and diet restrictions. Treating the whole patient by identifying malnourishment, dermatologic conditions, and psychosocial needs can help ensure that IBD doesn’t have any negative impacts beyond the gut. Join Dr. Matt Birnholz as he digests the highlights from the 2020 Crohn's and Colitis Congress session "IBD: Beyond the Gut" with guest Dr. James Lewis.

James D. Lewis, MD, MSCE, from the University of Pennsylvania, discusses the role of diet in Crohn disease, his research on the association between reduced consumption of red and processed meats and risk of symptomatic relapse of Crohn disease, and more.

Host: Kelly Issokson, MS, RD, CNSC Guest: James D. Lewis, MD, MSCE After the “Nutritional Therapy for IBD: From Theory to Your Practice” session at the second annual Crohn’s & Colitis Congress in Las Vegas, dietician Kelly Issokson and Dr. James Lewis recap the key takeaways, how you can implement those takeaways into your practice, and the benefits of recruiting dieticians and other healthcare professionals to provide your IBD patients with nutritional therapy.

Host: Kelly Issokson, MS, RD, CNSC Guest: James D. Lewis, MD, MSCE After the “Nutritional Therapy for IBD: From Theory to Your Practice” session at the second annual Crohn’s & Colitis Congress in Las Vegas, dietician Kelly Issokson and Dr. James Lewis recap the key takeaways, how you can implement those takeaways into your practice, and the benefits of recruiting dieticians and other healthcare professionals to provide your IBD patients with nutritional therapy.

Host: Kelly Issokson, MS, RD, CNSC Guest: James D. Lewis, MD, MSCE After the “Nutritional Therapy for IBD: From Theory to Your Practice” session at the second annual Crohn’s & Colitis Congress in Las Vegas, dietician Kelly Issokson and Dr. James Lewis recap the key takeaways, how you can implement those takeaways into your practice, and the benefits of recruiting dieticians and other healthcare professionals to provide your IBD patients with nutritional therapy.

Host: Kelly Issokson, MS, RD, CNSC Guest: James D. Lewis, MD, MSCE After the “Nutritional Therapy for IBD: From Theory to Your Practice” session at the second annual Crohn’s & Colitis Congress in Las Vegas, dietician Kelly Issokson and Dr. James Lewis recap the key takeaways, how you can implement those takeaways into your practice, and the benefits of recruiting dieticians and other healthcare professionals to provide your IBD patients with nutritional therapy.

Host: Lu Ann Cahn Guest: James D. Lewis, MD, MSCE Whether they’re not getting enough calories or not eating a balanced diet due to disease restrictions, patients with IBD often have difficulty maintaining a healthy diet. So how can you help them navigate these diet and nutrition challenges? Filmed live at the 2018 Crohn's and Colitis Evening of Hope, Dr. James Lewis from the University of Pennsylvania discusses strategies you can implement in your practice.

Host: Lu Ann Cahn Guest: James D. Lewis, MD, MSCE Whether they’re not getting enough calories or not eating a balanced diet due to disease restrictions, patients with IBD often have difficulty maintaining a healthy diet. So how can you help them navigate these diet and nutrition challenges? Filmed live at the 2018 Crohn's and Colitis Evening of Hope, Dr. James Lewis from the University of Pennsylvania discusses strategies you can implement in your practice.

Host: Lu Ann Cahn Guest: James D. Lewis, MD, MSCE Whether they’re not getting enough calories or not eating a balanced diet due to disease restrictions, patients with IBD often have difficulty maintaining a healthy diet. So how can you help them navigate these diet and nutrition challenges? Filmed live at the 2018 Crohn's and Colitis Evening of Hope, Dr. James Lewis from the University of Pennsylvania discusses strategies you can implement in your practice.

PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: Sofinnova Partners, Fidia Farmaceutici.Persone: Graziano Seghezzi (Sofinnova Partners), Nino Cartabellotta (Fondazione Gimbe), Anna Cereseto (Università di Trento), Pietro Invernizzi (Università di Milano-Bicocca), Andrea Giustina (Università Vita Salute San Raffaele di Milano), James D. Lewis (Università della Pennsylvania).Nuove terapie: fattore VIII porcino, paclitaxel/acido ialuronico.Patologie: colangite biliare primitiva, carcinoma differenziato della tiroide, malattia di Crohn, dolore cronico, emofilia A acquisita, carcinoma in situ della vescica.Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/Hai un dispositivo Apple? Seguici e abbonati al podcast tramite la app iPod http://nelfarmaceutico.link/pharma-apple

PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: Sofinnova Partners, Fidia Farmaceutici.Persone: Graziano Seghezzi (Sofinnova Partners), Nino Cartabellotta (Fondazione Gimbe), Anna Cereseto (Università di Trento), Pietro Invernizzi (Università di Milano-Bicocca), Andrea Giustina (Università Vita Salute San Raffaele di Milano), James D. Lewis (Università della Pennsylvania).Nuove terapie: fattore VIII porcino, paclitaxel/acido ialuronico.Patologie: colangite biliare primitiva, carcinoma differenziato della tiroide, malattia di Crohn, dolore cronico, emofilia A acquisita, carcinoma in situ della vescica.Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/Hai un dispositivo Apple? Seguici e abbonati al podcast tramite la app iPod http://nelfarmaceutico.link/pharma-apple

A study in the November issue of CGH investigated whether increasing doses of mesalamine reduces concentrations of fecal calprotectin in patients with quiescent ulcerative colitis. Dr. Kuemmerle speaks to author Dr. James D. Lewis.